CNTX · CIK 0001842952 · operating
Context Therapeutics Inc. (CNTX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $207 million, Context Therapeutics Inc. is a micro-cap company. The stock currently trades at $2.29, up 1.56% today, with a 52-week range of $0.49–$2.85.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.46 | $-0.46 | +69.3% | |
| 2023 | $-1.50 | $-1.50 | -61.3% | |
| 2022 | $-0.93 | $-0.93 | +74.8% | |
| 2021 | $-3.69 | $-3.69 | — |